NCT00912145View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

February 29, 1996

Primary Completion Date

February 29, 1996

Study Completion Date

February 29, 1996

Conditions

Anxiety

Interventions

DRUG

Alprazolam Tablets, 2 mg (Geneva Pharmaceuticals, Inc.)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY